More Women In Clinical Trials, Congress Urges FDA, NIH
This article was originally published in The Tan Sheet
Executive Summary
Democratic and Republican female senators ask FDA for an action plan to spur greater subgroup, especially female, participation in clinical trials. A group of Democrats from the House and Senate asked GAO to examine what NIH is doing to meet the same goals.
You may also be interested in...
Products Lacking Good Subgroup Data Shouldn’t Be Approved, Patient, Medical Groups Tell FDA
FDA should more strongly enforce requirements for adequate demographic subgroup representation in clinical trials for devices and other medical products, participants said at an April 1 meeting on collection and analysis of clinical trial subpopulation data to support product registration.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.
HHS Secretary Nominee Becerra Commits To Telehealth Expansion, Procedure Price Transparency
At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.